PIII p3hp.org: Koefisien utang jangka dawa marang modal

PIII (P3 Health Partners, Inc.) - tandha merek perusahaan

P3 Health Partners Inc. (PIII) cloud IT solutions ensure service stability, while a focus on preventive medicine reduces the environmental footprint. The long-term debt-to-equity ratio clearly demonstrates the balance sheet dynamics, while 1.58 records a new level. However, a sharp increase in government healthcare spending has hit margins, triggering an acute liquidity shortage and the need for restructuring.

P3 Health (PIII): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Produk merek P3 Health Partners Inc.

P3 Health Partners Inc. (PIII) is developing a value-based healthcare model for seniors where the cost of complex clinical cases is already integrated into the tariffs. This indicator is calculated as the ratio of liabilities with a maturity of over one year to equity. The metric allows for an assessment of the business's dependence on external borrowing. It is critical for investors to understand whether the debt load fuels growth or creates a default risk. The trend of the long-term debt-to-equity ratio objectively confirms the issuer's financial stability.

Pesaing P3 Health Partners Inc.

Rasio silihan jangka dawa marang modal HCA|Tenet (THC) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Fresenius Medical (FMS)|SOLV: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal encompasshealth.com EHC|Universal Health Services Corp - Utang jangka dawa marang modal|DaVita HealthCare Partners (DVA) - Utang jangka dawa marang modal|RDNT - Rasio utang jangka dawa marang ekuitas|OPCH (Option Care Corp) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas SGRY|Rasio utang jangka dawa marang ekuitas premierinc.com|National Vision - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal PGNY (Progyny Inc)|ARDT - Utang jangka dawa marang ekuitas|SEM - Rasio utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Astrana Health, Inc. ASTH|MD: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas usph.com (USPH)|Kewajiban jangka dawa marang ekuitas Pennant Group|Rasio utang jangka dawa marang ekuitas ORGO|NUTX: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal AUNA|SBC (SBC Medical Group Holdings Inc.) - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal EOLS (Evolus)|CHS (CYH) - Utang jangka dawa marang modal|Beauty Health - Kewajiban jangka dawa marang modal|MDWD - Utang jangka dawa marang modal|biote Corp. (BTMD) - Utang jangka dawa marang modal|JYNT (thejoint.com) - Utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas DCGO|GANX (Gain Therapeutics Inc.) - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal EUDA|BMGL (baselmedical.com) - Utang jangka dawa marang modal|CollPlant Biotechnologies Ltd. - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas CUPR|CCM - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas AMS|MRM: Kewajiban jangka dawa marang ekuitas|Avalon GloboCare Corp. (ALBT) - Utang jangka dawa marang modal|Utang jangka dawa marang modal DIH Holding US, Inc.|XAGE: Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal NIVF (NewGenIvf)|Rasio utang jangka dawa marang ekuitas ATIP|Rasio silihan jangka dawa marang modal CareMax Medical Group CMAX|KDLY: Utang jangka dawa marang ekuitas|ModivCare Inc. - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal novointegrated.com|sunlinkhealth.com (SSY) - Kewajiban jangka dawa marang modal|IMAC Holdings Inc - Utang jangka dawa marang ekuitas